Your browser doesn't support javascript.
loading
Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy.
Wang, Yu; Xue, Yu-Juan; Zuo, Ying-Xi; Jia, Yue-Ping; Lu, Ai-Dong; Zeng, Hui-Min; Zhang, Le-Ping.
Afiliação
  • Wang Y; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Xue YJ; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Zuo YX; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Jia YP; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Lu AD; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Zeng HM; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China. zenghuimin@pkuph.edu.cn.
  • Zhang LP; Department of Pediatrics, Peking University People's Hospital, Peking University, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
J Transl Med ; 22(1): 680, 2024 Jul 26.
Article em En | MEDLINE | ID: mdl-39061064

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígenos CD19 Limite: Adult / Female / Humans / Male Idioma: En Revista: J Transl Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígenos CD19 Limite: Adult / Female / Humans / Male Idioma: En Revista: J Transl Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
...